
Two clinical trials are currently underway in the U.S. to evaluate the effect of rapamycin on Long COVID and myalgic encephalomyelitis (ME) — one at Mount Sinai’s Cohen Center for Recovery from Complex Chronic Illness and another at Simmaron Research.

When I signed up for a clinical trial, I expected it to be thought provoking at best and onerous at worst. I didn’t expect it to change my life.

There’s a story in Greek mythology where Orpheus, a gifted poet and musician, travels to the underworld to rescue his newly wedded wife, Eurydice, who died after being bitten by a snake. They are both allowed to leave Hades under one condition: Eurydice must walk behind Orpheus, and he must not turn and look back…
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance